Gene · 445
Papers3,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,861 to 1,880 of 3,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Wnt proteins as modulators of synaptic plasticity. | Curr Opin Neurobiol | 2018 | 29975877 | PubTator, text mining | PubMed |
| A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies. | Cancer Chemother Pharmacol | 2018 | 29971467 | PubTator, text mining | PubMed |
| Scientific Advances and New Frontiers in Mesothelioma Therapeutics. | J Thorac Oncol | 2018 | 29966799 | PubTator, text mining | PubMed |
| Granulocytic dysplasia: an indicator of clonal evolution in patients with chronic myeloid leukemia. | Blood Res | 2018 | 29963531 | PubTator, text mining | PubMed |
| New tricks for an ancient system: Physiological and pathological roles of complement in the CNS. | Mol Immunol | 2018 | 29958698 | PubTator, text mining | PubMed |
| Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening. | Mol Genet Metab Rep | 2018 | 29946514 | PubTator, text mining | PubMed |
| Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders. | Acta Neuropathol | 2018 | 29934874 | PubTator, text mining | PubMed |
| Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. | Acta Neuropathol | 2018 | 29934873 | PubTator, text mining | PubMed |
| Genome wide analysis of TLR1/2- and TLR4-activated SZ95 sebocytes reveals a complex immune-competence and identifies serum amyloid A as a marker for activated sebaceous glands. | PLoS One | 2018 | 29927962 | PubTator, text mining | PubMed |
| [Identification of a homozygous ASS1 mutation in a child with citrullinemia type Ⅰ with high-melting curve method]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2018 | 29896748 | PubTator, text mining | PubMed |
| Sources and Fates of Carbamyl Phosphate: A Labile Energy-Rich Molecule with Multiple Facets. | Biology (Basel) | 2018 | 29895729 | PubTator, text mining | PubMed |
| Pre- and postnatal exposure of mice to concentrated urban PM2.5 decreases the number of alveoli and leads to altered lung function at an early stage of life. | Environ Pollut | 2018 | 29883952 | PubTator, text mining | PubMed |
| The Citrulline Recycling Pathway Sustains Cardiovascular Function in Arginine-Depleted Healthy Mice, but Cannot Sustain Nitric Oxide Production during Endotoxin Challenge. | J Nutr | 2018 | 29878271 | PubTator, text mining | PubMed |
| Novel 1q22-q23.1 duplication in a patient with lambdoid and metopic craniosynostosis, muscular hypotonia, and psychomotor retardation. | J Appl Genet | 2018 | 29845577 | PubTator, text mining | PubMed |
| p53 and metabolism: from mechanism to therapeutics. | Oncotarget | 2018 | 29805774 | PubTator, text mining | PubMed |
| Intrinsic Disorder and Posttranslational Modifications: The Darker Side of the Biological Dark Matter. | Front Genet | 2018 | 29780404 | PubTator, text mining | PubMed |
| Metabolic therapy with PEG-arginase induces a sustained complete remission in immunotherapy-resistant melanoma. | J Hematol Oncol | 2018 | 29776373 | PubTator, text mining | PubMed |
| Induction of Nitric-Oxide Metabolism in Enterocytes Alleviates Colitis and Inflammation-Associated Colon Cancer. | Cell Rep | 2018 | 29768197 | PubTator, text mining | PubMed |
| Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity. | Cell Metab | 2018 | 29754953 | PubTator, text mining | PubMed |
| A gene interaction network‑based method to measure the common and heterogeneous mechanisms of gynecological cancer. | Mol Med Rep | 2018 | 29749503 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/445/papers?page=94